We are live on ! Find out more
SKYE icon

Skye Bioscience
SKYE

62 hedge funds and large institutions have $196M invested in Skye Bioscience in 2024 Q2 according to their latest regulatory filings, with 62 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

87.27% more ownership

Funds ownership: 0% → 87.27% (+87%)

0% more call options, than puts

Call options by funds: $9K | Put options by funds: $9K

Holders
62
Holders Change
+62
Holders Change %
–
% of All Funds
0.9%
Holding in Top 10
5
Holding in Top 10 Change
+5
Holding in Top 10 Change %
% of All Funds
0.07%
New
62
Increased
–
Reduced
–
Closed
–
Calls
$9K
Puts
$9K
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
5VM
5AM Venture Management
California
+$121M
2
VVM
Versant Venture Management
California
+$23.8M
3
ACM
Altium Capital Management
New York
+$16M
4
LGM
Logos Global Management
California
+$15.4M
5
SFM
Sphera Funds Management
Israel
+$15.4M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
5VM
1
5AM Venture Management
California
$81.5M +$121M +10,179,505 New
VVM
2
Versant Venture Management
California
$16.1M +$23.8M +2,007,704 New
ACM
3
Altium Capital Management
New York
$10.8M +$16M +1,350,093 New
LGM
4
Logos Global Management
California
$10.4M +$15.4M +1,301,518 New
SFM
5
Sphera Funds Management
Israel
$10.4M +$15.4M +1,298,312 New
BlackRock
6
BlackRock
New York
$8.96M +$13.3M +1,118,767 New
Janus Henderson Group
7
Janus Henderson Group
United Kingdom
$7.29M +$10.7M +905,650 New
Vanguard Group
8
Vanguard Group
Pennsylvania
$6.68M +$9.89M +833,620 New
CH
9
CVI Holdings
Delaware
$5.44M +$8.07M +679,739 New
DCM
10
Driehaus Capital Management
Illinois
$5.21M +$7.72M +650,758 New
Point72 Asset Management
11
Point72 Asset Management
Connecticut
$4.49M +$6.64M +560,000 New
BBA
12
Baker Bros. Advisors
New York
$4M +$5.93M +500,000 New
PA
13
Perceptive Advisors
New York
$4M +$5.93M +500,000 New
SSA
14
Schonfeld Strategic Advisors
New York
$3.46M +$5.12M +431,355 New
VCIM
15
Velan Capital Investment Management
Georgia
$3.38M +$5.01M +422,142 New
Geode Capital Management
16
Geode Capital Management
Massachusetts
$2.97M +$4.39M +370,179 New
State Street
17
State Street
Massachusetts
$2.65M +$3.93M +331,004 New
Alyeska Investment Group
18
Alyeska Investment Group
Illinois
$2.4M +$3.56M +300,000 New
Citadel Advisors
19
Citadel Advisors
Florida
$2.13M +$3.15M +265,587 New
Bank of New York Mellon
20
Bank of New York Mellon
New York
$471K +$697K +58,778 New
Charles Schwab
21
Charles Schwab
California
$414K +$613K +51,656 New
Northern Trust
22
Northern Trust
Illinois
$340K +$504K +42,469 New
Barclays
23
Barclays
United Kingdom
$339K +$502K +42,338 New
NIM
24
NEOS Investment Management
Connecticut
$253K +$376K +31,647 New
PAS
25
Point72 Asia (Singapore)
Singapore
$222K +$329K +27,768 New
1
2 3

SKYE Hedge Fund Activity: Q2 2024 in Review

62 of the 6,925 institutional investors tracked by Wall St. Rank reported a position in Skye Bioscience (SKYE) for Q2 2024, worth a combined $196M.

Buyers outnumbered sellers: 62 funds opened new SKYE positions and 0 closed out — a net gain of 62 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was 5AM Venture Management, opening a new position worth an estimated $121M.

  • 62 institutional investors held Skye Bioscience (SKYE) as of Q2 2024, up from 0 in Q1 2024.
  • Funds reported $196M of Skye Bioscience stock for Q2 2024.
  • 62 funds opened new Skye Bioscience positions in Q2 2024 and 0 closed out, a net change of +62 holders.
  • The largest Skye Bioscience buyer in Q2 2024 was 5AM Venture Management, an estimated $121M added.

Based on aggregated 13F filings for Q2 2024.